Graybug Vision, Inc. announced that two prominent industry executives have joined its management team. Charles P. Semba, MD, joins as Chief Medical Officer and Ward M. Peterson, PhD, joins as Senior Vice President of Preclinical Development. Dr. Semba joins Graybug Vision from the ophthalmic product company ForSight VISION5, Inc., where he was the Chief Medical Officer. He began his industry career at Genentech, Inc., first working as Medical Director in Cardiac & Vascular Biotherapeutics and later as Senior Group Director in Ophthalmology & Tissue Growth and Repair. As an industry consultant since 2010, Dr. Petersen has been working with Graybug Vision to design and implement nonclinical studies of GB-102. He also co-founded and serves as President of the early stage company Symberix, Inc.